Regulation2 June 2026
· 8 min read
Here is a pattern worth sitting with. The two largest technology waves of the last fifteen years — first crypto, then AI — both grew up in the same place: the part of the world where you can do math without asking permission. Not because math is glamorous, and not because the people working on it were unusually brave. Because math, for a brief window, was the last domain a regulator hadn’t reached. You could write an algorithm, publish it, and run it before anyone had a form to fill out.
Regulation2 June 2026
· 7 min read
Picture the payoff matrix a drug reviewer actually faces. Approve something that later hurts people, and the failure has a name, a face, and a hearing room. Block — or just slow-walk — something that would have saved lives, and nothing happens to you at all, because the people it would have saved never knew the drug existed. One quadrant ends careers. The other is invisible. Put a rational person in that matrix and they will, on the margin, say no. Not because they’re cowardly or captured, but because the incentives were built that way.
Regulation2 June 2026
· 6 min read
The expensive part of regulatory compliance was never the document. It was everything you didn’t do because of it.
Picture a hardware team that wants to revise a part. The change is good. But it triggers a re-evaluation against a few hundred pages of standards, and that re-evaluation costs weeks of specialist time. So the change doesn’t happen. The design freezes — not because freezing is correct, but because thawing is too expensive. Multiply that across every decision in a regulated product and you get the real cost of compliance: a slow, invisible tax on iteration. Teams stop changing things that should change.